Qubit Pharmaceuticals
Quantum Science & Computing · Drug Discovery
$3Mraised in 2 rounds
$202krevenue · 2024 · French register
3backers · Audacia, Omnes Capital
$3Mgrants · 2 grants · CORDIS
Overview
Qubit Pharmaceuticals applies high-performance computing, molecular simulation and quantum algorithms to drug discovery. Its Atlas platform models how candidate molecules bind to targets in order to shorten the early discovery phase. The company is headquartered in Paris and was spun out of academic research in France and the United States.
Funding and backers
Team
20–49
French register · Dec 2023
Grants
$3M
2 grants · CORDIS
Revenue
$202k
2024 · French register
Backers
3
Audacia, Omnes Capital
Momentum
0/100
no fresh signals
Last sign of life
2 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 1, 2025
Won a grant $314k · CORDIS
Sep 10, 2025
Increased its share capital $22k · BODACC
Sep 1, 2022
Won a grant $2.7M · CORDIS
Jul 7, 2022
Increased its share capital $18k · BODACC
Apr 1, 2020
Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | QUBIT PHARMACEUTICALS | recherche-entreprises |
| Registered | 1 Apr 2020 |
Founders and leadersfrom filings, registers and the company's site
Robert MarinoPrésident de SAScompany register
Backed byfrom the funds' portfolios and accelerator catalogs
Audacia Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
From idea to drug molecule in days™. Tell our agent your target and it will handle the rest. The first fully autonomous drug discovery…
We provide the networking solutions for building the infrastructure of the quantum revolution: scalable quantum computing and secure…
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict…
Quandela is a deep-tech company and quantum hardware manufacturer specializing in full-stack photonic quantum computing. Headquartered in…
Accelerate drug discovery with physics-based AI. Deep Origin combines simulations and machine learning to predict molecular properties and…
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
People
Robert Marino
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
QuantonationVia a fund
Omnes CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum Computing
Read more
Report
Qubit Pharmaceuticals Accelerates Drug Discovery With Hybrid Quantum Computing
Startup Qubit Pharmaceuticals is significantly reducing the time and investment needed for drug discovery with by accelerating drug molecule simulation and modeling with hybrid quantum computing.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ
50-200 est. staff